U.S. flag

An official website of the United States government

IAP CMS Commentary

Showing 1 to 5 of 5 results

Tyler Sadwith, Health Insurance Specialist, Disabled and Elderly Health Programs Group, CMCS

For the past two years, The Medicaid Innovation Accelerator Program (IAP) has been working with Medicaid and behavioral health agencies to develop robust approaches for addressing substance use disorders (SUD). As described in the IAP High Intensity Learning Collaborative fact sheet , we have been...

Karen LLanos, Director, Medicaid IAP and Tyler Sadwith, Health Insurance Specialist, Disabled and Elderly Health Programs Group, CMCS

After a year and a half working with Medicaid and behavioral health agencies to develop robust approaches for addressing substance use disorders, we have much to share with states. As described in the Medicaid Innovation Accelerator Program (IAP) High Intensity Learning Collaborative (HILC)...

John O'Brien, Senior Policy Advisor, CMCS and Tyler Sadwith, Health Insurance Specialist, Disabled and Elderly Health Programs Group, CMCS

As the need for developing robust approaches for addressing substance use disorders becomes increasingly clear, CMS has been working directly with a set of leader states through our Medicaid Innovation Accelerator Program (IAP). Seven states participate in an intensive learning collaborative and 48...

Cindy Mann, JD, CMS Deputy Administrator and Director, Center for Medicaid and CHIP Services

We were so pleased with the turnout and lively discussion at our series of in-person meetings where states and stakeholders shared their feedback on our new Medicaid Innovation Accelerator Program. It was great to see so many state colleagues in person and we were pleased with the high level of...

John O'Brien, Senior Policy Advisor, CMCS and David Shillcutt, Disabled and Elderly Health Programs Group

We are excited to confirm that the first IAP focus area will address strategies to improve states substance use disorder (SUD) treatment systems. SUD is a serious and growing problem in the U.S., but evidence is also strong for the efficacy and cost-effectiveness of treatment. Based on...

Show entries